Nampt: linking NAD biology, metabolism and cancer

被引:330
作者
Garten, Antje [1 ]
Petzold, Stefanie [1 ]
Koerner, Antje [1 ]
Imai, Shin-ichiro [2 ]
Kiess, Wieland [1 ]
机构
[1] Univ Leipzig, Hosp Children & Adolescents, Res Lab, D-04317 Leipzig, Germany
[2] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA
关键词
COLONY-ENHANCING FACTOR; NICOTINAMIDE ADENINE-DINUCLEOTIDE; PLASMA VISFATIN CONCENTRATIONS; STIMULATED INSULIN-SECRETION; SERUM VISFATIN; INCREASED DOSAGE; VISCERAL FAT; BETA-CELLS; LIFE-SPAN; SIR2;
D O I
10.1016/j.tem.2008.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to nicotinamide mononucleotide (NMN), a key nicotinamide adenine dinucleotide (NAD) intermediate. Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biology, metabolism and inflammation. As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses. Nampt also plays an important part in regulating insulin secretion in pancreatic beta-cells. Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation. This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 93 条
[41]  
LI Y, J BIOL CHEM IN PRESS
[42]   Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease [J].
Lin, SJ ;
Guarente, L .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :241-246
[43]   Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity [J].
Luk, Tracy ;
Malam, Zeenat ;
Marshall, John C. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (04) :804-816
[44]   Enzymology of NAD+ synthesis [J].
Magni, G ;
Amici, A ;
Emanuelli, M ;
Raffaelli, N ;
Ruggieri, S .
ADVANCES IN ENZYMOLOGY, VOL 73, 1999, 73 :135-+
[45]   Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity [J].
Malavazos, Alexis E. ;
Ermetici, Federica ;
Cereda, Emanuele ;
Coman, Calin ;
Locati, Massimo ;
Morricone, Lelio ;
Corsi, Massimiliano M. ;
Ambrosi, Bruno .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (08) :523-530
[46]   Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence [J].
Martin, PR ;
Shea, RJ ;
Mulks, MH .
JOURNAL OF BACTERIOLOGY, 2001, 183 (04) :1168-1174
[47]   Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes [J].
Milne, Jill C. ;
Lambert, Philip D. ;
Schenk, Simon ;
Carney, David P. ;
Smith, Jesse J. ;
Gagne, David J. ;
Jin, Lei ;
Boss, Olivier ;
Perni, Robert B. ;
Vu, Chi B. ;
Bemis, Jean E. ;
Xie, Roger ;
Disch, Jeremy S. ;
Ng, Pui Yee ;
Nunes, Joseph J. ;
Lynch, Amy V. ;
Yang, Hongying ;
Galonek, Heidi ;
Israelian, Kristine ;
Choy, Wendy ;
Iffland, Andre ;
Lavu, Siva ;
Medvedik, Oliver ;
Sinclair, David A. ;
Olefsky, Jerrold M. ;
Jirousek, Michael R. ;
Elliott, Peter J. ;
Westphal, Christoph H. .
NATURE, 2007, 450 (7170) :712-716
[48]   Visfatin, an adipocytokine with proinflammatory and immunomodulating properties [J].
Moschen, Alexander R. ;
Kaser, Arthur ;
Enrich, Barbara ;
Mosheimer, Birgit ;
Theurl, Milan ;
Niederegger, Harald ;
Tilg, Herbert .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1748-1758
[49]   Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice [J].
Moynihan, KA ;
Grimm, AA ;
Plueger, MM ;
Bernal-Mizrachi, E ;
Ford, E ;
Cras-Méneur, C ;
Permutt, MA ;
Imai, SI .
CELL METABOLISM, 2005, 2 (02) :105-117
[50]   Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy [J].
Muruganandham, M ;
Alfieri, A ;
Matei, C ;
Chen, YC ;
Sukenick, G ;
Schemainda, I ;
Hasmann, M ;
Saltz, LB ;
Koutcher, JA .
CLINICAL CANCER RESEARCH, 2005, 11 (09) :3503-3513